Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Alexander Powers

Neurological Surgery Kernersville, NC Medical Doctor

NPI 1134397714 CMS profile 993857

280 Broad St Ste A, Kernersville, NC 27284

Open in the dashboard

General payments

$1,713,405

375 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Alexander Powers of Kernersville, NC is reported in the CMS Open Payments database as having received $1,713,405 across 375 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $74,584 70
2024 General $250,805 56
2023 General $335,206 63
2022 General $320,598 52
2021 General $117,407 58
2020 General $234,685 25
2019 General $380,121 51

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alexander Powers
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Alexander Powers were reported at $74,584. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Alexander Powers Neurological Surgery median Middle half National median
2019 $380,121 $582 $138–$3,006 $163
2020 $234,685 $294 $76–$2,174 $114
2021 $117,407 $387 $105–$2,432 $132
2022 $320,598 $542 $139–$2,989 $149
2023 $335,206 $534 $145–$2,697 $160
2024 $250,805 $574 $155–$3,046 $164
2025 $74,584 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $1,422,831 82 payments
  2. Globus Medical, Inc. $270,821 106 payments
  3. Biedermann Motech, Inc. $7,770 9 payments
  4. Medacta USA, Inc. $6,561 33 payments
  5. Medtronic, Inc. $1,536 54 payments
  6. Orthofix Medical, Inc. $926 11 payments
  7. Cerapedics, Inc. $425 4 payments
  8. Boston Scientific Corporation $405 23 payments
  9. Medtronic USA, Inc. $354 11 payments
  10. NuVasive, Inc. $333 8 payments
  11. Other $1,443 34 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $1,630,167 61 payments
  2. Consulting Fee $57,400 8 payments
  3. Travel and Lodging $12,033 49 payments
  4. Food and Beverage $9,606 254 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,000 1 payment
  6. Education $198 2 payments
Products named General payments · program years 2019–2025
  1. SERRATO Thoracolumbar $788,759 14 payments
  2. SERRATO Thoracolumbar $590,176 26 payments
  3. Hedron Spine/Spine Surgery $66,822 8 payments
  4. Hedron C $61,106 12 payments
  5. HEDRON Spine $44,335 8 payments
  6. Hedron IC Spine/Spine Surgery $43,719 7 payments
  7. HEDRON Spine/Joint $33,506 8 payments
  8. AIRO $19,073 2 payments
  9. HEDRON IC Spine $17,245 2 payments
  10. EVEREST SPINAL SYSTEM $14,315 14 payments
  11. Other $103,057 310 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 11 drugs

Part D claims

634

Median for Neurosurgery: 83

Drug cost

$7,488

Median for Neurosurgery: $872

Branded share of claims

33.3%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 149 $2,127
Cyclobenzaprine Hcl Generic 148 $1,392
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 62 $1,127
Tizanidine Hcl Generic 57 $844
Gabapentin Generic 43 $567
Tramadol Hcl Generic 26 $429
Oxycodone Hcl Generic 43 $397
Ciprofloxacin Hcl Generic 33 $222
Methylprednisolone Generic 26 $184
Diazepam Generic 36 $174

The 10 drugs with the highest cost, of 11 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 44 billing codes

Paid by Medicare

$126,721

Medicare's payments for the services billed

Medicare patients

127

Average age 70

Services billed

409

70 women, 57 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Depression 38%
Diabetes 31%
Ischemic heart disease 28%
COPD 24%
Chronic kidney disease 22%
Osteoporosis 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

375 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record